North America $1.4 Bn Cancer Vaccines Market, 2022 - Research and Markets

DUBLIN--()--The "North America Cancer Vaccines Market - Segmented by Type, Technology, End User and Geography 2017 - 2022" report has been added to Research and Markets' offering.

The North America market is currently estimated to be valued at USD 1405 million for the year 2015 the market is expected to grow at a CAGR of 12-20% over the period (2017 - 2022).

The market for cancer vaccines is much smaller than other cancer therapeutic categories. The size of the market can be attributed to the nascent stages of industry life cycle and the late introduction of the vaccines in the market. To tap this market, many companies from North America are actively investing in cancer vaccine development. The market penetration is expected to increase with the increase in competition among the various pharmaceutical companies to obtain a larger portion of this market.

Some of the key participants in the industry include Prima BioMed, GlaxoSmithKline, Sanofi S.A, Merck, Aduro BioTech, AstraZeneca plc, OXFORD BIOMEDICA etc.

Key Topics Covered:

1. Executive Summary

2. Research Methodology

3. Introduction

4. Market Overview

5. Porters Five Force Analysis

6. Market Segmentation

7. Competitive Landscape

8. Company Profiles

  • AstraZeneca plc
  • Aduro BioTech
  • Cytos
  • Galena Biopharma
  • Juvaris Biotherapeutics
  • MedImmune
  • Oxford BioMedica
  • Prima BioMed
  • GlaxoSmithKline
  • Sanofi
  • Merk&co
  • Ubivac
  • Vaccinogen

For more information about this report visit https://www.researchandmarkets.com/research/fsbz46/north_america

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Cancer Vaccines

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Cancer Vaccines